The Hip Replacement Market Size was valued at USD 7.22 Bn in 2022 and is expected to reach USD 10.50 Bn by 2030 and grow at a CAGR of 5.1% over the forecast period of 2023-2030.
Hip replacement surgery, sometimes referred to as hip arthroplasty, involves replacing a diseased or injured hip joint with an artificial joint, usually referred to as a prosthesis or implant. When various non-surgical treatments have failed to sufficiently relieve hip pain and impairment, it is typically undertaken. Where the femur (thigh bone) meets the pelvis, a ball-and-socket joint called the hip is formed. The femoral head, which is the ball element of the joint and is positioned at the top of the femur, and the acetabulum, which is located in the pelvis, are both given these names. The injured femoral head and the diseased cartilage in the acetabulum are removed during a hip replacement procedure and replaced with prosthetic parts.
The prosthetic hip joint normally comprises of a plastic, metal, or ceramic socket that replaces the injured acetabulum and a metal or ceramic ball that serves as the replacement for the femoral head. Using bone cement or osseointegration, in which the implant generates bone and fuses to it, the prosthesis can be fastened to the bone.
In order to reach the hip joint during hip replacement surgery, the surgeon creates an incision on the side or back of the hip. The replacement parts are implanted and secured in place after the harmed bone and cartilage are removed. The patient is subsequently transferred to a recovery area after the incision has been stitched up.
Driver
The rising cases of osteoarthritis.
The awareness of the high-quality life for the patients suffering from the adverse physical condition.
The results of hip replacement surgery can significantly alter a person's general quality of life. People can engage in activities including walking, climbing stairs, exercising, and engaging in leisure activities again thanks to pain relief, improved mobility, and function restoration. This may result in a more rewarding, active, and joyful way of life.
Restrain
The risk associated with the surgery.
Infection, blood clots, anaesthesia issues, blood vessel or nerve injury, joint dislocation, and prosthesis failure are some of the hazards associated with hip replacement surgery, as are those associated with any surgical operation. Although these dangers are quite minor, surgeons take measures to reduce them.
Challenge
The Pre-health conditions can create issues for the patients in terms of recovery, or any other adverse effects.
Opportunity
The rising technological advancement in the healthcare industry and the rising investments for the same.
It may be difficult to obtain the medical devices, implants, and materials required for hip replacement surgery if the conflict affects trade routes or causes trade restrictions. This may cause delays or restrictions when carrying out the processes.
Conflict conditions may cause healthcare workers to leave the impacted areas. The availability of specialised surgeons and healthcare professionals with training in hip replacement surgery may be impacted by this loss of competent staff. Healthcare staff and resources may be shifted during times of conflict to treat war-related injuries and provide emergency care. When resources are devoted to urgent and essential situations, elective treatments like hip replacements may experience delays or capacity limitations.
Impact of Recession.
As people and governments limit their budgets, healthcare spending frequently declines during recessions. As a result, healthcare systems may experience financial difficulties, which could have an impact on the accessibility and availability of hip replacement surgeries. Due to resource constraints, hospitals and healthcare facilities may need to put vital treatments ahead of elective procedures.
In areas where healthcare is publicly funded, a recession may result in increasing demand when supplies are scarce. Longer waiting periods for elective procedures, such as hip replacements, may arise from this. Patients' quality of life and functional capacities may be impacted by delays in receiving essential surgical procedures.
By Procedure
Total Replacement
Partial Replacement
Revision & Hip Resurfacing
By End-User
Hospitals & Ambulatory Surgery Centers
Orthopedic Clinics
Others
.png)
One of the biggest markets in the world for hip replacements is in North America.
Due to its significant ageing population, high rate of osteoarthritis, and sophisticated healthcare system, the United States makes a significant contribution. Zimmer Biomet, and Stryker Corporation are important participants in this market. The market is expanding as a result of technological developments such the utilisation of minimally invasive procedures and cutting-edge materials.
Due to reasons such a sizable ageing population, rising healthcare costs, and an improved healthcare infrastructure, the hip replacement industry is expanding quickly in the Asia-Pacific area.
The major key players are Zimmer Biomet, DePuy Synthes Companies, Smith & Nephew, Stryker, Exactech, Conformis, MicroPort Scientific Corporation, B. Braun Melsungen AG, Gruppo Bioimpianti and others.
Zimmer Biomet: Exclusive Multi-Year Co-Marketing Agreement for the HipInsightTM Mixed Reality System for Total Hip Replacement is Announced by Zimmer Biomet and Surgical Planning Associates.
Stryker: The launch of Insignia Hip Stem at the American academy of Orthopaedic Surgeons.
| Report Attributes | Details |
| Market Size in 2022 | US$ 7.22 Bn |
| Market Size by 2030 | US$ 10.50 Bn |
| CAGR | CAGR of 5.1% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Procedure (Total Replacement, Partial Replacement, Revision & Hip Resurfacing) • By End-User (Hospitals & Ambulatory Surgery Centers, Orthopedic Clinics, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Zimmer Biomet, DePuy Synthes Companies, Smith & Nephew, Stryker, Exactech, Conformis, MicroPort Scientific Corporation, B. Braun Melsungen AG, Gruppo Bioimpianti |
| Key Drivers | • The rising cases of osteoarthritis. • The awareness of the high-quality life for the patients suffering from the adverse physical condition. |
| Market Restraints | • The risk associated with the surgery. |
Ans: The Compound Annual Growth rate for Hip Replacements Market over the forecast period is 5.1%.
Ans. The Hip Replacement Market Size was valued at USD 7.22 Bn in 2022 and is expected to reach USD 10.50 Bn by 2030 and grow at a CAGR of 5.1% over the forecast period of 2023-2030.
Ans. North America is the fastest growing region of the Hip Replacements Market.
Ans. The major key players are Zimmer Biomet, DePuy Synthes Companies, Smith & Nephew, Stryker, Exactech, Conformis, MicroPort Scientific Corporation, B. Braun Melsungen AG, Gruppo Bioimpianti and others.
Ans. The rising cases of osteoarthritis. and the awareness of the high-quality life for the patients suffering from the adverse condition.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Hip Replacement Market Segmentation, by Procedure
8.1 Total Replacement
8.2 Partial Replacement
8.3 Revision & Hip Resurfacing
9. Hip Replacement Market Segmentation, by End User
9.1 Hospitals & Ambulatory Surgery Centers
9.2 Orthopedic Clinics
9.3 Others
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Hip Replacement Market by Country
10.2.2North America Hip Replacement Market by Procedure
10.2.3 North America Hip Replacement Market by End-User
10.2.4 USA
10.2.4.1 USA Hip Replacement Market by Procedure
10.2.4.2 USA Hip Replacement Market by End-User
10.2.5 Canada
10.2.5.1 Canada Hip Replacement Market by Procedure
10.2.5.2 Canada Hip Replacement Market by End-User
10.2.6 Mexico
10.2.6.1 Mexico Hip Replacement Market by Raw Technology
10.2.6.2 Mexico Hip Replacement Market by End-User
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Hip Replacement Market by Country
10.3.1.2 Eastern Europe Hip Replacement Market by Procedure
10.3.1.3 Eastern Europe Hip Replacement Market by End-User
10.3.1.4 Poland
10.3.1.4.1 Poland Hip Replacement Market by Procedure
10.3.1.4.2 Poland Hip Replacement Market by End-User
10.3.1.5 Romania
10.3.1.5.1 Romania Hip Replacement Market by Procedure
10.3.1.5.2 Romania Hip Replacement Market by End-User
10.3.1.6 Hungary
10.3.1.6.1 Hungary Hip Replacement Market by Procedure
10.3.1.6.2 Hungary Hip Replacement Market by End-User
10.3.1.7 Turkey
10.3.1.7.1 Turkey Hip Replacement Market by Procedure
10.3.1.7.2 Turkey Hip Replacement Market by End-User
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Hip Replacement Market by Procedure
10.3.1.8.2 Rest of Eastern Europe Hip Replacement Market by End-User
10.3.2 Western Europe
10.3.2.1 Western Europe Hip Replacement Market by Country
10.3.2.2 Western Europe Hip Replacement Market by Procedure
10.3.2.3 Western Europe Hip Replacement Market by End-User
10.3.2.4 Germany
10.3.2.4.1 Germany Hip Replacement Market by Procedure
10.3.2.4.2 Germany Hip Replacement Market by End-User
10.3.2.5 France
10.3.2.5.1 France Hip Replacement Market by Procedure
10.3.2.5.2 France Hip Replacement Market by End-User
10.3.2.6 UK
10.3.2.6.1 UK Hip Replacement Market by Procedure
10.3.2.6.2 UK Hip Replacement Market by End-User
10.3.2.7 Italy
10.3.2.7.1 Italy Hip Replacement Market by Procedure
10.3.2.7.2 Italy Hip Replacement Market by End-User
10.3.2.8 Spain
10.3.2.8.1 Spain Hip Replacement Market by Procedure
10.3.2.8.2 Spain Hip Replacement Market by End-User
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Hip Replacement Market by Procedure
10.3.2.9.2 Netherlands Hip Replacement Market by End-User
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Hip Replacement Market by Procedure
10.3.2.10.2 Switzerland Hip Replacement Market by End-User
10.3.2.11 Austria
10.3.2.11.1 Austria Hip Replacement Market by Procedure
10.3.2.11.2 Austria Hip Replacement Market by End-User
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Hip Replacement Market by Procedure
10.3.2.12.2 Rest of Western Europe Hip Replacement Market by End-User
10.4 Asia-Pacific
10.4.1 Asia Pacific Hip Replacement Market by Country
10.4.2 Asia Pacific Hip Replacement Market by Procedure
10.4.3 Asia Pacific Hip Replacement Market by End-User
10.4.4 China
10.4.4.1 China Hip Replacement Market by Procedure
10.4.4.2 China Hip Replacement Market by End-User
10.4.5 India
10.4.5.1 India Hip Replacement Market by Procedure
10.4.5.2 India Hip Replacement Market by End-User
10.4.6 Japan
10.4.6.1 Japan Hip Replacement Market by Procedure
10.4.6.2 Japan Hip Replacement Market by End-User
10.4.7 South Korea
10.4.7.1 South Korea Hip Replacement Market by Procedure
10.4.7.2 South Korea Hip Replacement Market by End-User
10.4.8 Vietnam
10.4.8.1 Vietnam Hip Replacement Market by Procedure
10.4.8.2 Vietnam Hip Replacement Market by End-User
10.4.9 Singapore
10.4.9.1 Singapore Hip Replacement Market by Procedure
10.4.9.2 Singapore Hip Replacement Market by End-User
10.4.10 Australia
10.4.10.1 Australia Hip Replacement Market by Procedure
10.4.10.2 Australia Hip Replacement Market by End-User
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Hip Replacement Market by Procedure
10.4.11.2 Rest of Asia-Pacific APAC Hip Replacement Market by End-User
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Hip Replacement Market by Country
10.5.1.2 Middle East Hip Replacement Market by Procedure
10.5.1.3 Middle East Hip Replacement Market by End-User
10.5.1.4 UAE
10.5.1.4.1 UAE Hip Replacement Market by Procedure
10.5.1.4.2 UAE Hip Replacement Market by End-User
10.5.1.5 Egypt
10.5.1.5.1 Egypt Hip Replacement Market by Procedure
10.5.1.5.2 Egypt Hip Replacement Market by End-User
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Hip Replacement Market by Procedure
10.5.1.6.2 Saudi Arabia Hip Replacement Market by End-User
10.5.1.7 Qatar
10.5.1.7.1 Qatar Hip Replacement Market by Procedure
10.5.1.7.2 Qatar Hip Replacement Market by End-User
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Hip Replacement Market by Procedure
10.5.1.8.2 Rest of Middle East Hip Replacement Market by End-User
10.5.2 Africa
10.5.2.1 Africa Hip Replacement Market by Country
10.5.2.2 Africa Hip Replacement Market by Procedure
10.5.2.3 Africa Hip Replacement Market by End-User
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Hip Replacement Market by Procedure
10.5.2.4.2 Nigeria Hip Replacement Market by End-User
10.5.2.5 South Africa
10.5.2.5.1 South Africa Hip Replacement Market by Procedure
10.5.2.5.2 South Africa Hip Replacement Market by End-User
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Hip Replacement Market by Procedure
10.5.2.6.2 Rest of Africa Hip Replacement Market by End-User
10.6 Latin America
10.6.1 Latin America Hip Replacement Market by Country
10.6.2 Latin America Hip Replacement Market by Procedure
10.6.3 Latin America Hip Replacement Market by End-User
10.6.4 Brazil
10.6.4.1 Brazil Hip Replacement Market by Procedure
10.6.4.2 Brazil Africa Hip Replacement Market by End-User
10.6.5 Argentina
10.6.5.1 Argentina Hip Replacement Market by Procedure
10.6.5.2 Argentina Hip Replacement Market by End-User
10.6.6 Colombia
10.6.6.1 Colombia Hip Replacement Market by Procedure
10.6.6.2 Colombia Hip Replacement Market by End-User
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Hip Replacement Market by Procedure
10.6.7.2 Rest of Latin America Hip Replacement Market by End-User
11 Company Profile
11.1 Zimmer Biomet
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 DePuy Synthes Companies
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Smith & Nephew
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Stryker
11.4 Company Overview
11.4.2 Financials
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Exactech
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Conformis
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 MicroPort Scientific Corporation
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 B. Braun Melsungen AG
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Gruppo Bioimpianti
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Others
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Chlamydia Infection Treatment Market Size was valued at USD 2.82 billion in 2022 and is expected to reach USD 5.41 billion by 2030 and grow at a CAGR of 8.5% over the forecast period 2023-2030.
The Oral Care Market size was valued at USD 38.88 Bn in 2022 and is expected to reach USD 61.51 by Bn by 2030, with a growig CAGR of CAGR of 5.9% over the forecast period 2023-2030.
The Ultrasound gels market size is projected to grow from $95.85 million in 2022 to $124.2 million by 2030, at a CAGR of 3.3% during the forecast period.
The Bispecific Antibodies Market size was estimated USD 5.8 billion in 2022 and is expected to reach USD 106.1 billion by 2030 at a CAGR of 43.8% during the forecast period of 2023-2030.
The Diet Pills Market size is expected to reach USD 3.04 Bn by 2030 and was valued at USD 1.45 Bn in 2022, the CAGR is expected to be 9.7% over the forecast period of 2023-2030.
The Electronic Health Records [EHR] Market size was esteemed at US$ 29.15 billion in 2023 and is projected to reach US$ 39.89 billion by 2031, enlisting a CAGR of 4% from 2024 to 2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
